FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4615411000001101: Lidocaine 0.66% / Aminoacridine 0.05% oral gel (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
14965701000001113 Lidocaine 0.66% / Aminoacridine 0.05% oral gel (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
62006101000001114 Lidocaine 0.66% / Aminoacridine 0.05% oromucosal gel en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lidocaine 0.66% / Aminoacridine 0.05% oral gel Has NHS dm+d (dictionary of medicines and devices) dose form indicator Continuous dose form indicator true Inferred relationship Existential restriction modifier
Lidocaine 0.66% / Aminoacridine 0.05% oral gel Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Gingival route true Inferred relationship Existential restriction modifier
Lidocaine 0.66% / Aminoacridine 0.05% oral gel Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route gel.oromucosal ontology form and route true Inferred relationship Existential restriction modifier
Lidocaine 0.66% / Aminoacridine 0.05% oral gel Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oromucosal route true Inferred relationship Existential restriction modifier
Lidocaine 0.66% / Aminoacridine 0.05% oral gel Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lidocaine 0.66% / Aminoacridine 0.05% oral gel Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route gel.gingival ontology form and route true Inferred relationship Existential restriction modifier
Lidocaine 0.66% / Aminoacridine 0.05% oral gel Has active ingredient Aminoacridine hydrochloride false Inferred relationship Existential restriction modifier
Lidocaine 0.66% / Aminoacridine 0.05% oral gel Has manufactured dose form Gel false Inferred relationship Existential restriction modifier
Lidocaine 0.66% / Aminoacridine 0.05% oral gel Has active ingredient Lidocaine hydrochloride false Inferred relationship Existential restriction modifier
Lidocaine 0.66% / Aminoacridine 0.05% oral gel Is a Aminoacridine + Lidocaine false Inferred relationship Existential restriction modifier
Lidocaine 0.66% / Aminoacridine 0.05% oral gel Has active ingredient Aminoacridine hydrochloride false Inferred relationship Existential restriction modifier
Lidocaine 0.66% / Aminoacridine 0.05% oral gel Has manufactured dose form Gel false Inferred relationship Existential restriction modifier
Lidocaine 0.66% / Aminoacridine 0.05% oral gel Is a Lidocaine + Aminoacridine true Inferred relationship Existential restriction modifier
Lidocaine 0.66% / Aminoacridine 0.05% oral gel VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lidocaine 0.66% / Aminoacridine 0.05% oral gel VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lidocaine 0.66% / Aminoacridine 0.05% oral gel Is a Product containing aminoacridine and lidocaine false Inferred relationship Existential restriction modifier
Lidocaine 0.66% / Aminoacridine 0.05% oral gel Has specific active ingredient Aminoacridine hydrochloride true Inferred relationship Existential restriction modifier
Lidocaine 0.66% / Aminoacridine 0.05% oral gel Has specific active ingredient Lidocaine hydrochloride true Inferred relationship Existential restriction modifier
Lidocaine 0.66% / Aminoacridine 0.05% oral gel Has active ingredient Aminoacridine false Inferred relationship Existential restriction modifier
Lidocaine 0.66% / Aminoacridine 0.05% oral gel Has active ingredient Lidocaine false Inferred relationship Existential restriction modifier
Lidocaine 0.66% / Aminoacridine 0.05% oral gel Has dispensed dose form Gel false Inferred relationship Existential restriction modifier
Lidocaine 0.66% / Aminoacridine 0.05% oral gel Has manufactured dose form Oromucosal AND/OR gingival dosage form false Inferred relationship Existential restriction modifier
Lidocaine 0.66% / Aminoacridine 0.05% oral gel Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Lidocaine 0.66% / Aminoacridine 0.05% oral gel Has dispensed dose form Conventional release oromucosal gel true Inferred relationship Existential restriction modifier
Lidocaine 0.66% / Aminoacridine 0.05% oral gel Has manufactured dose form Conventional release oromucosal gel false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Medijel oromucosal gel (Dendron Brands Ltd) Is a True Lidocaine 0.66% / Aminoacridine 0.05% oral gel Inferred relationship Existential restriction modifier
Lidocaine 0.66% / Aminoacridine 0.05% oral gel 15 gram Is pack of False Lidocaine 0.66% / Aminoacridine 0.05% oral gel Inferred relationship Existential restriction modifier
Medijel oral gel (Doncaster Pharmaceuticals Ltd) Is a True Lidocaine 0.66% / Aminoacridine 0.05% oral gel Inferred relationship Existential restriction modifier
Lidocaine 0.66% / Aminoacridine 0.05% oral gel 15 gram Has VMP True Lidocaine 0.66% / Aminoacridine 0.05% oral gel Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start